73
Participants
Start Date
August 31, 2010
Primary Completion Date
September 9, 2019
Study Completion Date
September 9, 2019
Everolimus
10 mg by mouth once a day.
Sunitinib
50 mg by mouth daily for 4 weeks on / 2 weeks off
University of Texas MD Anderson Cancer Center, Houston
Huntsman Cancer Institute - University of Utah, Salt Lake City
Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
Novartis
INDUSTRY
M.D. Anderson Cancer Center
OTHER